Get startedLog in
    Picture of Shanghai Henlius Biotech logo

    2696 — Shanghai Henlius Biotech News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Henlius Biotech shareholders reject take-private offer from China's Fosun

    Picture of Shanghai Henlius Biotech logoShanghai Henlius Biotech
    22/01/2025 11:15
    Jan 22 (Reuters) - Shareholders of Shanghai Henlius
Biotech  2696.HK  rejected Chinese conglomerate Fosun
International's  0656.HK  offer to buy the Hong Kong-listed
drugmaker, the companies said on Wednesday.

 (Reporting by Aaditya Govind Rao in Bengaluru; Editing by Savio
D'Souza)
 ((Aaditya.GovindRao@thomsonreuters.com;))

    Recent news on Shanghai Henlius Biotech

    See all news